There is growing evidence that certain specific groups and characteristics make some individuals more vulnerable to COVID-19. The purpose of this health questionnaire is to only help and inform both the employee and their employment agency on how to identify those individuals with underlying conditions or have identified increased risk factor(s) that may put them at increased or extreme risk in the workplace.
The risk that someone will get the infection through work can be reduced through control measures that minimise workplace exposure and through use of personal protective equipment. People who are clinically extremely vulnerable are at high risk of getting seriously ill from coronavirus (COVID-19). If you considered clinically extremely vulnerable, should have received a letter advising you to shield or have been told by your GP or hospital clinician.
There is significant concern at present about possible increased vulnerability for BAME individuals, particularly those working in healthcare roles where they may be at increased risk of exposure. It is unclear at present whether this represents an additional vulnerability related to ethnicity or whether this represents an increase in the comorbidities in this group that are known to increase vulnerability.
The NHS now say that you would be considered at very high risk if ALL THREE of these things apply to you:
• You have asthma, AND
• You are taking certain extra controller medicines as well as a preventer inhaler (for example, you are taking Montelukast, salmeterol or formoterol, or you are on a combination inhaler like Seretide, Fostair, Symbicort, Flutiform, Fobumix, DuoResp Spiromax, Combisal, Sereflo, Sirdupla, Aloflute, AirFluSal, Relvar Ellipta, Fusacomb or Stalpex), AND
• You are taking continuous or frequent oral steroids.
Existing guidance identifies that pregnant women over 28 weeks should be regarded as at increased risk and recommended to stay at home. For pregnant women with underlying health conditions at any stage of pregnancy a more precautionary approach is required, and ethnicity should be included in the consideration and discussion between healthcare staff and managers. Where pregnancy is under 28 weeks gestation working in a patient facing environment should be on the basis that the risk assessment supports this.
Association of Local Authority Medical Advisors (ALAMA):
https://alama.org.uk/covid-19-medical-risk-assessment/
Healthier Business UK- Candidates home page:
https://www.hbcompliance.co.uk/candidate-news/corona-virus-information-for-hcws/
Asthma:
https://www.asthma.org.uk/advice/triggers/coronavirus-covid-19/shielding-advice-high-risk/
Cancer and Covid-19:
https://www.cancerresearchuk.org/about-cancer/cancer-in-general/coronavirus-and-cancer
Cardiovascular Conditions and COVID-19:
https://www.bhf.org.uk/informationsupport/heart-matters-magazine/news/coronavirus-and-your-health
Diabetes and COVID-19:
https://www.diabetes.org.uk/about_us/news/coronavirus
Haematological conditions and COVID-19:
https://news.wfh.org/specific-risks-of-covid-19-to-the-bleeding-disorders-community/
Inflammatory Bowel Disease and COVID-19:
https://www.bsg.org.uk/covid-19-advice/bsg-advice-for-management-of-inflammatory-bowel-diseases-during-the-covid-19-pandemic/
Neurological conditions and COVID-19:
https://alama.org.uk/covid-19-medical-risk-assessment/neurological-conditions-and-covid-19/
Pituitary Disorders and COVID-19:
https://pituitary.org.uk/news/2020/03/coronavirus-advice/
Pregnancy and COVID-19:
https://www.rcog.org.uk/globalassets/documents/guidelines/2020-04-27-occupational--health--advice--for--employers-and--pregnant-women.pdf
Renal Conditions and COVID-19:
https://www.kidneycareuk.org/news-and-campaigns/coronavirus-advice/
Respiratory conditions and COVID-19:
https://www.blf.org.uk/support-for-you/coronavirus/what-is-social-shielding